DHL Supply Chain is going bigger in healthcare and medicine delivery, thanks to a new one-million-square-foot distribution center in Annville, Pennsylvania.
What’s Related
The facility is designed to move medical products and drugs faster and more reliably across the East Coast. It sits near major highways and includes temperature-controlled space for sensitive medicines, solar power systems, and charging stations for electric vehicles. Once it opens later this year, the site will also operate as a Foreign Trade Zone, which can help speed up customs processes and reduce some tariff delays.
“As pharmaceutical companies navigate tariff changes, rising demand for temperature-controlled infrastructure, and strict regulatory compliance, they need logistics partners with proven expertise,” said Mark Kunar, CEO of DHL Supply Chain North America. He called the Annville site “a critical next step” in how DHL supports the healthcare industry.
The new facility is part of a larger push by DHL to grow its life sciences and healthcare business. That effort also includes the recent acquisition of SDS Rx, a U.S. delivery company with more than 200 local locations focused on health care and final-mile delivery. The deal expands DHL’s reach into deliveries for specialty pharmacies, long-term care facilities, and hospital systems.
“Final-mile delivery is a critical component of the health care logistics ecosystem,” Kunar said after the SDS Rx deal closed. “With SDS Rx now part of our network, we are well positioned to serve health systems, care centers, and patients with precision, speed, and care.”
Together, the new Pennsylvania facility and the expanded delivery network are giving DHL a major push in U.S. healthcare logistics. That added reach comes at a time when demand for specialty drugs, biologics, and tightly regulated medical shipments continues to grow.
